Regencell Bioscience Holdings Limited (RGC)
NasdaqCM
Price as at 1 Oct 2026, 00:13 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Regencell Bioscience Holdings Limited trades at $6.22. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Politician trades in RGC
Trades in RGC disclosed by members of Congress and executive-branch officials, latest first:
- Gary Palmer · HouseBuy · $1,001 - $15,000 · traded 4 Apr 2017 · disclosed 29 Sept 2018
A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.
Common questions
Where does SteadyShares get its RGC data?
Fundamentals for RGC come from company filings and exchange data, as listed on NasdaqCM; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 00:13 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for RGC, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.